← Leaderboards
Zackery P. Bulman
University Of Illinois At Chicago
$2,580,287
Attributed
$2,927,501
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$2,927,501 · 3
By mechanism
R01$2,233,072 · 1
R21$694,429 · 2
Top collaborators
- Liang Chen1 shared
- Yury Polikanov1 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Alex A Neyfakh$1,012,907
- Alexander S Mankin$8,923,069
- Yury Polikanov$4,048,503
Others in their field
Other Rising Stars on “Resistance”
- Supriya Menezes · The Emmes Company, Llc$18,394,958
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Heinz Ernst Moser · University Of Texas Med Br Galveston$12,973,432
- Chris Maxwell · National Institute Of Allergy And Infectious Diseases$12,000,000
- Andrew Tomaras · Forge Therapeutics, Inc.$10,977,909
- Christine W Hockett · Avera Mckennan$8,908,366
Research focus
ResistanceInsightInfectionFiberAntibioticsSynergismSiteTreatment FailurePathogenLifeMolecularCombatCombined Modality TherapyMouse ModelPenetrationInnovationAminoglycosidesFutureCeftazidimeBlood CirculationAntibiotic TherapyInhibitorIn VivoClinical Treatment
Grant awards (5)
Precise Combination Strategies Targeting Carbapenem-Resistant Klebsiella pneumoniae$720,276
R01 · FY2025 · AI · contact PI
Innovative Antibiotic Combinations for Hypervirulent Klebsiella pneumoniae$456,911
R21 · FY2025 · AI · contact PI
Structural, functional, and microbiological exploration toward synergistic dual aminoglycoside combinations$237,518
R21 · FY2025 · AI · contact PI
Precise Combination Strategies Targeting Carbapenem-Resistant Klebsiella pneumoniae$728,907
R01 · FY2024 · AI · contact PI
Precise Combination Strategies Targeting Carbapenem-Resistant Klebsiella pneumoniae$783,889
R01 · FY2023 · AI · contact PI